Skip to content

Immunity Booster effect of Cordyplan

Efficacy Evaluation/Clinical Trial of Perforance Enhancer Product-Cordyplan Developed by DIBER (DRDO) Haldwani

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073147
Enrollment
60
Registered
2024-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D899- Disorder involving the immune mechanism, unspecified

Interventions

None listed

Sponsors

Defence Institute of Bio-Energy Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients are selected irrespective of sex, occupation, caste, etc. 2.The patients between ages of 20 to 60 years are included in the study. 3.Patients with classical signs and symptoms of low Immunity mentioned earlier will be taken for the study.

Exclusion criteria

Exclusion criteria: Subjects associated with systemic illness such as Diabetes, Cancer, CKD. Patients who leave the treatment in between. Subjects with anatomical deformity. Subjects with pregnancy. Patient not willing to participate.

Design outcomes

Primary

MeasureTime frame
Effect on immunological profile viz. a, ß, y globulins, IgG, IgM Complete Blood Count Random Blood Sugar Level LFT Kidney Function Test Two times viz. First at the time of initiation of study and second, after one month of study Timepoint: before Study and after one months at the end of study

Secondary

MeasureTime frame
Effect on Liver function Test, Kidney Function Test & Blood Sugar Level after three month of study to access long term Effect of drug Timepoint: after 3 months of study

Countries

India

Contacts

Public ContactDr Ajay Kumar

GOVERNMENT AYURVEDIC COLLEGE and HOSPITAL

prakashrajsingh65@gmail.com9415228314

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026